Pfizer is down -9.7%, or -$2.78 to $25.80.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PFE:
- Pfizer’s (NYSE:PFE) Disappointing FY24 Guidance Rattles Investors
- Goldman Sachs Says These 3 Healthcare Giants Look Very Attractive Right Now
- M & A News: Pfizer (NYSE:PFE) to Seal $43B Seagen Deal, Analyst Remains Upbeat
- Unusually active option classes on open December 12th
- Pfizer price target lowered by $6 at Morgan Stanley, here’s why